Expert: Specialty Pharmacy is Changing, “Needs to Go Where the Patients Are” in the Future

Ray Tancredi, RPh, MBA, divisional VP of specialty pharmacy development and brand Rx/vaccine purchasing at Walgreens, provides an analysis and overview of key specialty pharmaceuticals in development.

Pharmacy Times interviewed Ray Tancredi, RPh, MBA, divisional VP of specialty pharmacy development and brand Rx/vaccine purchasing at Walgreens, on his presentation at the Asembia 2021 Specialty Summit on specialty pharmaceuticals in development.

During the discussion, Tancredi addressed some of the key trends in specialty drug development of late, how the category of “specialty pharmacy” is changing within the field, and some recent FDA approvals that are uniquely impacting the market.